39267-03-3 Usage
Uses
Used in Pharmaceutical Synthesis:
2,6-Dichloro-7-Methylquinoxaline is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the formation of heterocyclic compounds, which are essential in the development of various medicinal agents.
Used in Agrochemical Production:
In the agrochemical industry, 2,6-Dichloro-7-Methylquinoxaline serves as an intermediate, playing a crucial role in the creation of compounds that can be used in the development of pesticides and other agricultural chemicals to protect crops and enhance yield.
Used in Organic Compounds Synthesis:
2,6-Dichloro-7-Methylquinoxaline is utilized as a building block in the production of heterocyclic compounds and materials, which are vital in various chemical processes and applications due to their unique properties and structures.
While 2,6-Dichloro-7-Methylquinoxaline is not known to have any significant commercial or industrial uses outside of its role in chemical synthesis, its contribution to the synthesis of pharmaceuticals, agrochemicals, and other organic compounds highlights its importance in the development of new and innovative products across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 39267-03-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,2,6 and 7 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 39267-03:
(7*3)+(6*9)+(5*2)+(4*6)+(3*7)+(2*0)+(1*3)=133
133 % 10 = 3
So 39267-03-3 is a valid CAS Registry Number.
39267-03-3Relevant articles and documents
HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 57, (2009/07/10)
The present invention relates to compounds of formula wherein Ar, Het, R1 and n are as defined herein and to pharmaceutically suitable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. Compounds of formula I are orexin receptor antagonists and are useful in the treatment of sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder and sleep disorders associated with neurological diseases.
